NVAX
NOVAVAX (NVAX) Earnings
Review NOVAVAX (NVAX) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- 2.54
- Trailing EPS
- -1.52
- Annual revenue
- $1.12B
- Trailing revenue
- $413.80M
- Next earnings date
- 2026-08-06
- Earnings data source
- MarketBeat historical revenue consensus + Finnhub earnings
NOVAVAX (NVAX) Earnings research
The NVAX earnings page organizes the available earnings-per-share and revenue context for NOVAVAX. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.